Author： Papeo Gianluca Casale Elena Montagnoli Alessia Cirla Alessandra
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.4, 2013-04, pp. : 503-514
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Discussion of PARP inhibitors in cancer therapy
Pharmaceutical Patent Analyst, Vol. 2, Iss. 6, 2013-11 ,pp. :
Access to resources
Recommend
Role of PARP Inhibitors in Cancer Biology and Therapy
Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. :
Parp Inhibitors for the Treatment of Ovarian Cancer
Current Cancer Drug Targets, Vol. 18, Iss. 9, 2018-11 ,pp. :
Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Current Cancer Drug Targets, Vol. 12, Iss. 3, 2012-03 ,pp. :
Antiemetic therapy in cancer: an update
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. :